In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Dynacare goes public

Executive Summary

Dynacare (clinical lab testing services company headquartered in Ontario) completed its initial public offering of 5mm shares at $10. It was a disappointing transaction, as the company had registered last month hoping to sell 7mm shares at $13-15. PaineWebber, listed among the underwriters on the red herring, did not appear on the final prospectus.
Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register